← The Wire
ADMANasdaq
ADMA BIOLOGICS, INC.
Biological Products, (No Diagnostic Substances) · DE · CIK 1368514
Manufactures, markets, and develops specialty biologics for immunodeficient patients and those at risk for infectious diseases
$1.90B
Market cap
$8.37
Last close
-4.3%
1D
-2.3%
5D
4.3M
Volume
Price · last 39 sessions-18.8%
May 4L $7.60 · H $10.31Jun 29
427
Total filings
Jun 2, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 2, 202610-Q10-QMay 6, 20268-KResults of OperationsMay 6, 20268-KCompany UpdateMay 4, 2026DEFA14ADEFA14AApr 15, 2026DEF 14ADEF 14AApr 15, 20268-KReg FD DisclosureMar 27, 20268-KReg FD Disclosure · Company UpdateMar 2, 202610-K10-KFeb 25, 20268-KExecutive Change · Results of OperationsFeb 25, 20268-KResults of Operations · Reg FD DisclosureJan 12, 202610-Q10-QNov 5, 20258-KResults of OperationsNov 5, 202510-Q10-QAug 6, 20258-KMaterial Agreement · Agreement TerminatedAug 6, 20258-KShareholder VoteJun 4, 202510-Q10-QMay 7, 20258-KResults of Operations · Company UpdateMay 7, 20258-KCompany UpdateApr 28, 2025DEFA14ADEFA14AApr 15, 2025DEF 14ADEF 14AApr 15, 202510-K10-KMar 18, 20258-KResults of OperationsMar 3, 20258-KExecutive ChangeFeb 21, 20258-KReg FD DisclosureJan 13, 20258-KResults of OperationsJan 13, 20258-KExecutive ChangeJan 2, 20258-KCompany UpdateDec 20, 20248-KExecutive ChangeNov 21, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 2024SC 13GSC 13GNov 4, 20248-KAuditor ChangeOct 31, 20248-KReg FD DisclosureOct 10, 20248-KAuditor ChangeOct 9, 2024SC 13GSC 13GSep 23, 20248-KCompany UpdateAug 14, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KExecutive ChangeJul 26, 20248-KBylaw AmendmentJun 28, 20248-KShareholder VoteJun 4, 20248-KReg FD DisclosureMay 17, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AApr 15, 2024DEF 14ADEF 14AApr 15, 20248-KExecutive ChangeApr 2, 20248-KCompany UpdateMar 11, 20248-KReg FD DisclosureMar 5, 202410-K10-KFeb 28, 20248-KExecutive Change · Company UpdateFeb 28, 20248-KResults of OperationsFeb 28, 20248-KCompany UpdateFeb 21, 2024SC 13GSC 13GFeb 14, 2024SC 13GSC 13GFeb 14, 2024SC 13GSC 13GFeb 14, 2024SC 13GSCHEDULE 13GFeb 13, 20248-KReg FD DisclosureJan 8, 20248-KResults of OperationsJan 8, 20248-KMaterial Agreement · Agreement TerminatedDec 18, 20238-KCompany UpdateDec 12, 20238-KCompany UpdateNov 16, 202310-Q10-QNov 8, 20238-KResults of OperationsNov 8, 20238-KExecutive ChangeOct 2, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 9, 20238-KCompany UpdateJul 19, 20238-KShareholder VoteJun 6, 2023DEFA14ADEFA14AMay 22, 20238-KCompany UpdateMay 22, 202310-Q10-QMay 10, 20238-KResults of OperationsMay 10, 20238-KMaterial Agreement · Equity IssuanceMay 2, 2023DEFA14ADEFA14AApr 13, 2023DEF 14ADEF 14AApr 13, 202310-K10-KMar 23, 20238-KResults of OperationsMar 23, 20238-KExecutive ChangeMar 10, 2023
Insider Activity
In the 90 days to Mar 16, 2026: 1 insider bought $217K · 2 sold $814K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Grossman Adam SPresident and CEO | Sell | 15,000 | $15.16 | $227K |
| Mar 16, 2026 | Grossman Adam SPresident and CEO | Sell | 6,000 | $15.16 | $91K |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M.COO and SVP, Compliance | Sell | 10,096 | $15.63 | $158K |
| Mar 6, 2026 | Elms SteveDirector | Buy | 7,000 | $15.39 | $108K |
| Mar 5, 2026 | Elms SteveDirector | Buy | 7,000 | $15.67 | $110K |
| Feb 17, 2026 | Grossman Adam SPresident and CEO | Sell | 15,000 | $16.08 | $241K |
| Feb 17, 2026 | Grossman Adam SPresident and CEO | Sell | 6,000 | $16.08 | $96K |
| Dec 15, 2025 | Grossman Adam SPresident and CEO | Sell | 15,000 | $19.79 | $297K |
| Dec 15, 2025 | Grossman Adam SPresident and CEO | Sell | 6,000 | $19.79 | $119K |
| Nov 19, 2025 | Grossman Adam SPresident and CEO | Sell | 15,000 | $16.00 | $240K |
| Nov 19, 2025 | Grossman Adam SPresident and CEO | Sell | 6,000 | $16.00 | $96K |
| Oct 24, 2025 | Grossman Adam SPresident and CEO | Sell | 15,000 | $16.00 | $240K |
| Oct 24, 2025 | Grossman Adam SPresident and CEO | Sell | 6,000 | $16.00 | $96K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance